Walgreen files US antitrust claims against Biogen over Tecfidera
MLex Summary: Walgreen Co. filed a US complaint accusing Biogen of unlawfully impairing competition from generic versions of its brand-name prescription drug Tecfidera, which is used to treat multiple sclerosis. According to...To view the full article, register now.
Already a subscriber? Click here to view full article